Comparable Long-Term Efficacy of Lopinavir/Ritonavir and Similar Drug-Resistance Profiles in Different HIV-1 Subtypes-Reference-Cited by-同舟云学术

Comparable Long-Term Efficacy of Lopinavir/Ritonavir and Similar Drug-Resistance Profiles in Different HIV-1 Subtypes

Published:2014-01-27 Issue:1 Volume:9 Page:e86239
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Grossman Zehava,Schapiro Jonathan M.,Levy Itzchak,Elbirt Daniel,Chowers Michal,Riesenberg Klaris,Olstein-Pops Karen,Shahar Eduardo,Istomin Valery,Asher Ilan,Gottessman Bat-Sheva,Shemer Yonat,Elinav Hila,Hassoun Gamal,Rosenberg Shira,Averbuch Diana,Machleb-Guri Keren,Kra-Oz Zipi,Radian-Sade Sara,Rudich Hagit,Ram Daniela,Maayan Shlomo,Agmon-Levin Nancy,Sthoeger Zev

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference70 articles.

1. UNAIDS (2013) UNAIDS Report on the Global AIDS Epidemic 2012. Available: http://wwwunaidsorg/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_enpdf.

2. Global trends in molecular epidemiology of HIV-1 during 2000–2007;J Hemelaar;AIDS,2011

3. V3 region genotyping of HIV isolates in northern Uganda: heteroduplex mobility assay, nucleotide sequence and phylogenetic analysis. Italian-Ugandan Cooperation AIDS Program;FM Buonaguro;Antibiot Chemother,1996

4. pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D;M Cornelissen;J Virol,1997

5. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants;JK Carr;Virology,1998

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spectrum of Atazanavir-Selected Protease Inhibitor-Resistance Mutations;Pathogens;2022-05-05

2. Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus C;PLOS Computational Biology;2021-09-07

3. Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus C;2020-09-25

4. Gag-protease coevolution shapes the outcome of lopinavir-inclusive treatment regimens in chronically infected HIV-1 subtype C patients;Bioinformatics;2019-02-12

5. HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya;AIDS;2018-11-13